Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$445,971
+$16,979 QoQ
Shares Held
1,756
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#3,802
of 4,664 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mullooly Asset Management, Inc. holds $1,014,880 across 2 Drug Manufacturers - General names. JNJ ranks #2 (43.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
4,503 | $568,909 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,756 | $445,971 |
All Filings in JNJ
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $445,971 | 1,756 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $428,992 | 1,755 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $363,197 | 1,755 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $325,226 | 1,754 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $267,770 | 1,753 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $288,064 | 1,737 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||